VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127 | -21.1% | 126 | +1.6% | 0.00% | – |
| Q2 2023 | $161 | +29.8% | 124 | +4.2% | 0.00% | – |
| Q1 2023 | $124 | +4.2% | 119 | +1.7% | 0.00% | – |
| Q4 2022 | $119 | – | 117 | +3.5% | 0.00% | – |
| Q3 2022 | $0 | – | 113 | +5.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 107 | -99.1% | 0.00% | – |
| Q1 2022 | $48,000 | -72.7% | 11,988 | -30.9% | 0.00% | – |
| Q4 2021 | $176,000 | -69.4% | 17,339 | -51.4% | 0.00% | – |
| Q3 2021 | $576,000 | +585.7% | 35,641 | +448.3% | 0.00% | – |
| Q2 2021 | $84,000 | +16.7% | 6,500 | +73.0% | 0.00% | – |
| Q1 2021 | $72,000 | +132.3% | 3,758 | +150.5% | 0.00% | – |
| Q4 2020 | $31,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |